Skip to main content

Table 3 Associations between PFAS concentrations in early pregnancy and gestational age (in weeks) at birth

From: Perfluoroalkyl substances exposure in early pregnancy and preterm birth in singleton pregnancies: a prospective cohort study

PFAS (ng/ml)

β (95% CI)

Adjusteda β (95% CI)

PFOA

0.00 (−0.13, 0.14)

−0.00 (−0.14, 0.13)

PFNA

0.03 (−0.07, 0.14)

0.03 (−0.08, 0.13)

PFDA

0.03 (− 0.06, 0.12)

0.04 (− 0.05, 0.13)

PFUA

0.07 (− 0.02, 0.16)

0.06 (− 0.03, 0.15)

PFOS

−0.02 (− 0.12, 0.08)

0.02 (− 0.08, 0.12)

PFHxS

− 0.02 (− 0.15, 0.10)

−0.02 (− 0.14, 0.11)

PFHpA

0.02 (− 0.04, 0.07)

0.02 (− 0.05, 0.08)

PFBS

− 0.01 (− 0.09, 0.07)

0.02 (− 0.05, 0.10)

PFDoA

0.10 (− 0.01, 0.20)

0.08 (− 0.02, 0.19)

  1. Note: PFAS concentrations were measured in maternal plasma and have been ln-transformed before entering into the model
  2. aAdjusted for maternal age (years), pre-pregnancy BMI (kg/m2), parity (0, ≥ 1), parental educational levels (≤ 12, > 12 years), pregnancy complicating with chronic diseases (no, yes), infant sex (male, female) and gestational age at blood drawn (weeks)